IL-2 Receptor Antagonist (Basiliximab) Is Associated with Rapid Fibrosis Progression in Patients with Recurrent Hepatitis C after Liver Transplantation Using Serial Biopsy Specimens.

Hanouneh, I A; Zein, N N; Lopez, R; Yerian, L; Fung, J; Eghtesad, B

Hanouneh, I A; Zein, N N; Lopez, R; Yerian, L; Fung, J; Eghtesad, B.

Afiliación

Hanouneh IA; Department of Internal Medicine.
Zein NN; Department of Gastroenterology and Hepatology.
Lopez R; Department of Quantitative Health Sciences.
Yerian L; Department of Anatomic Pathology.
Fung J; Department of General Surgery, Transplant Center, The Cleveland Clinic, Cleveland, Ohio, USA.
Eghtesad B; Department of General Surgery, Transplant Center, The Cleveland Clinic, Cleveland, Ohio, USA.

Int J Organ Transplant Med ; 1(1): 7-14, 2010.

Article en En | MEDLINE | ID: mdl-25013557

Palabras clave

Transplantation; cirrhosis; hepatitis C virus; interleukin receptor antagonist; liver; liver fibrosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Organ Transplant Med Año: 2010 Tipo del documento: Article Pais de publicación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google